SCHEMBL2199850

SCHEMBL2199850

Cc1ccc(Br)cc1C(=O)c1ccc(N)cc1Cl

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK13 O15264 5/20 0.52
MAPK12 P53778 5/20 0.52
MAPK11 Q15759 5/20 0.52
MAPK14 Q16539 5/20 0.52
CYP3A4 P08684 1/20 0.47
MAPT P10636 4/20 0.42
ALDH1A1 P00352 1/20 0.42
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41
HPGD P15428 1/20 0.41
ALOX15 P16050 1/20 0.41
CASP1 P29466 1/20 0.41
CYP2C19 P33261 1/20 0.41
JAK2 O60674 1/20 0.40
TYK2 P29597 1/20 0.40
CHRM2 P08172 1/20 0.39
CHRM3 P20309 1/20 0.39
MAOA P21397 1/20 0.39
HTR2C P28335 1/20 0.39
CHRNA4 P43681 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2857233 0.94 MAPK13 (0.52) MAPK13MAPK12MAPK11MAPK14CYP3A4
SCHEMBL5174489 0.85 CYP3A4 (0.50) MAPK13MAPK12MAPK11MAPK14CYP3A4
SCHEMBL2855620 0.83 MAPT (0.45) MAPK13MAPK12MAPK11MAPK14MAPT
SCHEMBL2854950 0.82 ALDH1A1 (0.47) MAPK13MAPK12MAPK11MAPK14MAPT
SCHEMBL7035012 0.81 CYP3A4 (0.48) MAPK13MAPK12MAPK11MAPK14CYP3A4
SCHEMBL2198191 0.81 SRD5A2 (0.47) MAPK13MAPK12MAPK11MAPK14CYP3A4
SCHEMBL7090488 0.80 JAK2 (0.53) CYP3A4MAPTALDH1A1HPGDALOX15
SCHEMBL5172393 0.80 MAPK13 (0.61) MAPK13MAPK12MAPK11MAPK14CYP3A4
SCHEMBL2857986 0.80 ALDH1A1 (0.45) MAPK13MAPK12MAPK11MAPK14MAPT
SCHEMBL2199593 0.79 CYP3A4 (0.44) MAPK13MAPK12MAPK11MAPK14CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7977387-B2 Aminobenzophenone compounds LEO PHARMA A/S (DK) 2011-07-12 US disclosed
CN-1826310-B Novel aminobenzophenone compounds LEO PHARMA AS 2010-07-21 CN disclosed
CN-1826310-A Novel aminobenzophenone compounds LEO PHARMA AS (DK) 2006-08-30 CN disclosed
US-20060166990-A1 Novel aminobenzophenone compounds LEO PHARMA A/S (DK) 2006-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060166990-A1 Novel aminobenzophenone compounds NFKBIA, UACA, ALDH7A1 MAPK13 1063/4885MAPK12 955/4885MAPK11 612/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.